Anti-Human IL17RB Reference Antibody (SM17)

Description: Anti-Human IL17RB (SM17) (BS11651) is a research-grade recombinant antibody targeting IL-17B receptor. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: IL-17Breceptor,CRL4,IL17RB,Cytokinereceptor-like4,IL-17RB,IL17BR,IL-17receptorB,Interleukin-17Breceptor,EVI27,Interleukin-17receptorB,IL17Rh1,IL-17Rh1,IL-17receptorhomolog1
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: SM17
Background: Interleukin-17 receptor B (IL17RB) is a ~55 kDa protein. Receptor for the pro-inflammatory cytokines IL17B and IL17E. May play a role in controlling the growth and/or differentiation of hematopoietic cells.
Note: For research use only. Not suitable for clinical or therapeutic use.